We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Might Gut Microbiota Be a Target for a Personalized Therapeutic Approach in Patients Affected by Atherosclerosis Disease?
- Authors
Ciccone, Marco Matteo; Lepera, Mario Erminio; Guaricci, Andrea Igoren; Forleo, Cinzia; Cafiero, Concetta; Colella, Marica; Palmirotta, Raffele; Santacroce, Luigi
- Abstract
In recent years, the increasing number of studies on the relationship between the gut microbiota and atherosclerosis have led to significant interest in this subject. The gut microbiota, its metabolites (metabolome), such as TMAO, and gut dysbiosis play an important role in the development of atherosclerosis. Furthermore, inflammation, originating from the intestinal tract, adds yet another mechanism by which the human ecosystem is disrupted, resulting in the manifestation of metabolic diseases and, by extension, cardiovascular diseases. The scientific community must understand and elucidate these mechanisms in depth, to gain a better understanding of the relationship between atherosclerosis and the gut microbiome and to promote the development of new therapeutic targets in the coming years. This review aims to present the knowledge acquired so far, to trigger others to further investigate this intriguing topic.
- Subjects
GUT microbiome; THERAPEUTICS; DRUG target; CARDIOVASCULAR diseases; METABOLIC disorders; ATHEROSCLEROSIS
- Publication
Journal of Personalized Medicine, 2023, Vol 13, Issue 9, p1360
- ISSN
2075-4426
- Publication type
Article
- DOI
10.3390/jpm13091360